{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:14:09Z","timestamp":1741839249954,"version":"3.38.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019720","name":"GlaxoSmithKline Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.arbres.2024.08.006","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T04:30:26Z","timestamp":1728016226000},"page":"156-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resectable Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization"],"prefix":"10.1016","volume":"61","author":[{"given":"Abel","family":"Garcia-Diaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Moyano-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Carmen","family":"Garrido-Navas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"de Miguel-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Exp\u00f3sito-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardino","family":"Alc\u00e1zar-Navarrete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ortu\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Landeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro J.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Garcia-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Lopez-Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Bayarri-Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.arbres.2024.08.006_bib0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arbres.2024.08.006_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.arbres.2024.08.006_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: epidemiology etiology, and prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin Chest Med"},{"issue":"12","key":"10.1016\/j.arbres.2024.08.006_bib0175","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","article-title":"Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.arbres.2024.08.006_bib0180","first-page":"9","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Lieping","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arbres.2024.08.006_bib0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2024.08.006_bib0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"de Bruin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.arbres.2024.08.006_bib0195","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5858\/arpa.2017-0388-CP","volume":"142","author":"Lindeman","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.arbres.2024.08.006_bib0200","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.758464","volume":"9","author":"Choudhury","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.arbres.2024.08.006_bib0205","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2017.00847","article-title":"Uses of next-generation sequencing technologies for the diagnosis of primary immunodeficiencies","volume":"8","author":"Seleman","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.arbres.2024.08.006_bib0210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13059-015-0693-2","article-title":"Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases","volume":"16","author":"Group","year":"2015","journal-title":"Genome Biol"},{"key":"10.1016\/j.arbres.2024.08.006_bib0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0148659","article-title":"Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection","volume":"11","author":"Bayarri-Lara","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arbres.2024.08.006_bib0220","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.3390\/cancers11111750","article-title":"Post-surgery circulating tumor cells and AXL overexpression as new poor prognostic biomarkers in resected lung adenocarcinoma","volume":"11","author":"de Miguel-P\u00e9rez","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arbres.2024.08.006_bib0225","doi-asserted-by":"crossref","first-page":"431","DOI":"10.21037\/tlcr.2017.07.03","article-title":"Biology and clinical significance of circulating tumor cell subpopulations in lung cancer","volume":"6","author":"O\u2019Flaherty","year":"2017","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.arbres.2024.08.006_bib0230","doi-asserted-by":"crossref","first-page":"84453","DOI":"10.18632\/oncotarget.11497","article-title":"EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells","volume":"7","author":"Cardenas","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.arbres.2024.08.006_bib0235","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1038\/s41388-022-02375-x","article-title":"EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization","volume":"41","author":"Gallardo","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.arbres.2024.08.006_bib0240","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"10.1016\/j.arbres.2024.08.006_bib0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arbres.2024.08.006_bib0250","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/annonc\/mds138","article-title":"Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor","volume":"23","author":"Hiltermann","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.arbres.2024.08.006_bib0255","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-011-1591-2","article-title":"Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression","volume":"132","author":"Alford","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.arbres.2024.08.006_bib0260","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.humpath.2011.12.004","article-title":"Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer","volume":"43","author":"Hussein","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.arbres.2024.08.006_bib0265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.arbres.2024.08.006_bib0270","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fmolb.2022.1074277","article-title":"Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception","volume":"9","author":"Roa-Colomo","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.arbres.2024.08.006_bib0275","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1101\/gad.305805.117","article-title":"A conduit to metastasis: circulating tumor cell biology","volume":"31","author":"Micalizzi","year":"2017","journal-title":"Genes Dev"},{"key":"10.1016\/j.arbres.2024.08.006_bib0280","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41416-022-01819-1","article-title":"Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade","volume":"127","author":"Eslami-S","year":"2022","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.arbres.2024.08.006_bib0285","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/1878-0261.12494","article-title":"Lymph-circulating tumor cells show distinct properties to blood-circulating tumor cells and are efficient metastatic precursors","volume":"13","author":"Mohammed","year":"2019","journal-title":"Mol Oncol"},{"key":"10.1016\/j.arbres.2024.08.006_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-021-00739-6","article-title":"Role of the ABL tyrosine kinases in the epithelial\u2013mesenchymal transition and the metastatic cascade","volume":"19","author":"Luttman","year":"2021","journal-title":"Cell Commun Signal"},{"issue":"24","key":"10.1016\/j.arbres.2024.08.006_bib0295","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.3390\/cancers14246127","article-title":"TP53 co-mutation status association with clinical outcomes in patients with EGFR-mutant non-small cell lung cancer","volume":"14","author":"Le","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arbres.2024.08.006_bib0300","doi-asserted-by":"crossref","first-page":"e120941","DOI":"10.1172\/jci.insight.120941","article-title":"Requirement for MUC5AC in KRAS-dependent lung carcinogenesis","volume":"3","author":"Bauer","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.arbres.2024.08.006_bib0305","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10753-018-0780-0","article-title":"NLRP3 inflammasome involves in the acute exacerbation of patients with chronic obstructive pulmonary disease","volume":"41","author":"Wang","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.arbres.2024.08.006_bib0310","doi-asserted-by":"crossref","first-page":"S2155","DOI":"10.21037\/jtd.2019.10.54","article-title":"Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis","volume":"11","author":"Parris","year":"2019","journal-title":"J Thorac Dis"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289624003600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289624003600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T09:23:08Z","timestamp":1741771388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289624003600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0300289624003600"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2024.08.006","relation":{},"ISSN":["0300-2896"],"issn-type":[{"type":"print","value":"0300-2896"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resectable Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2024.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}